Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

USMJ $20 Million Marijuana and CBD Sales Growth Plans Update Scheduled For Tomorrow

PURA, USMJ, PJET, ALKM

Dallas, Texas, March 28, 2022 (GLOBE NEWSWIRE) -- North American Cannabis Holdings, Inc. (OTC Pink: USMJ) today confirmed the company is scheduled to publish an update tomorrow with details on the recently announced plans that could add $20 million in sales on top of the company’s growing sales from its expanding ecommerce business.

The plan in general is to take advantage or the unexcepted opportunity to grow and sell adult use marijuana, in addition to also rapidly capturing the opportunity for USMJ’s recently acquired CBD sports nutrition beverage.

USMJ has recently confirmed its eligibility to apply for the new adult-use marijuana cultivation license recently passed into law in the State of New York.

In February, New York passed a new law to provide provisional marijuana cultivation licenses to existing hemp businesses.

USMJ has a subsidiary that has been growing hemp for CBD for the past four years. The subsidiary has received an invitation from the New York Office of Cannabis Management (OCM) to apply for the provisional adult-use cannabis license.

USMJ also recently relaunched the EVERx CBD Sports Nutrition Beverage after acquiring the product line from Puration, Inc. (OTC Pink: PURA) in exchange for a royalty agreement as part of an overall reorganization executed by the co-controlling parent company of USMJ, PURA and Priority Aviation, Inc. (OTC Pink: PJET).

The EVERx CBD Sports Nutrition Beverage relaunch took place at Arnold Schwarzenegger’s annual Arnold Sports Festival.

Between the EVERx and adult use marijuana opportunities, USMJ has developed a plan that it believes can generate a potential $20 million in sales over the next two years separate from the sales that can be generated from the company’s expanding ecommerce business.

USMJ is founded on the core belief that cannabis makes people's lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers. The Company operates USMJ.com and is dedicated to Ongoing Cannabis Consumer Product Development that it can incubate into Future Spin-offs.

USMJ has one spin-off and dividend issuance so far in its cannabis incubation operational history having issued shares of Puration, Inc. (OTC Pink: PURA) in the past. USMJ continues to work closely with PURA and recently acquired a CBD sports nutrition beverage product from PURA in a royalty agreement. The EVERx CBD Sports Nutrition Beverage acquired by USMJ is bottled by Alkame Holdings, Inc. (OTC Pink: ALKM).

Visit the company’s ecommerce site now and bookmark the site to watch for more coming announcements and updates: www.USMJ.com

Contact:
USMJ
Steven Rash
info@aciconglomerated.com
+1 (800) 861-1350

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.


Primary Logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today